The Irish Times

Shake-up at Valeant signals stunning fall from grace for J Michael Pearson

Shake-up at Valeant signals stunning fall from grace for J Michael Pearson

Pharmaceutical giant faces a growing list of questions from investors and regulators

Tue Mar 22 2016 - 17:51

Investors and directors discover it’s good to talk

Investors and directors discover it’s good to talk

The Bottom Line: a little communication with shareholders would go a long way

Wed Jul 23 2014 - 01:00

Valeant’s unsolicited bid for Allergan part of a cheeky business model

Valeant’s unsolicited bid for Allergan part of a cheeky business model

Valeant Pharmaceuticals is a drug company that doesn’t develop drugs – it runs a serial takeover operation

Fri Jun 20 2014 - 01:05

Bid for Botox maker injects more life into growing merger trend among drugmakers

Bid for Botox maker injects more life into growing merger trend among drugmakers

Canadian pharma firm teams up with Wall Street hedge fund mogul to mount hostile takeover of Allergan

Fri Apr 25 2014 - 01:10

YOU MAY ALSO LIKE...

The Irish Times ePaper